PTCE Practice Test

Answer choices

1. A. Sewer it because only controlled drugs can qualify as hazardous pharmaceutical waste
2. B. Determine the waste stream; use the hazardous process and do not sewer covered product
3. C. Place it in ordinary trash because opening the container removes waste controls
4. D. Return it to dispensable stock because hazardous pharmaceuticals cannot be discarded

Wrong-answer review

• A. Sewer it because only controlled drugs can qualify as hazardous pharmaceutical waste: Federal controlled-substance status and hazardous-waste status are separate regulatory classifications.
• C. Place it in ordinary trash because opening the container removes waste controls: Opening a container does not erase its hazardous-pharmaceutical waste requirements.
• D. Return it to dispensable stock because hazardous pharmaceuticals cannot be discarded: Hazardous waste requires a managed disposal stream rather than return to active stock.

Answer choices

1. A. Keep both entries because all amoxicillin suspensions have one universal concentration and date
2. B. Estimate the final strength from the bottle size and use the pharmacy's longest routine date
3. C. List only milligrams and omit the volume because suspension concentration does not use mL
4. D. Reconstitute to labeled strength and follow product-specific storage and discard dating

Answer choices

1. A. 15 days
2. B. 30 days
3. C. 45 days
4. D. 60 days

Answer choices

1. A. Treat the remainder as a refill because the original prescription was already used once; involve the pharmacist before completing that step
2. B. Convert the remaining quantity to Schedule IV so it can be dispensed
3. C. Dispense the remainder without checking how the original partial fill was documented
4. D. Refer the order to the pharmacist to verify whether the remaining quantity can be dispensed under the lawful partial-fill process

Answer choices

1. A. Prioritize immediate patient care and pharmacist intervention, then document facts; follow internal and MedWatch reporting procedures
2. B. Complete external paperwork first because a report replaces immediate clinical response; involve the pharmacist before completing that step
3. C. Diagnose the medication as the definite cause before documenting the event
4. D. Submit MedWatch only and omit the pharmacy's internal incident process

Answer choices

1. A. Dispense both automatically because anticoagulants cannot duplicate one another; involve the pharmacist before completing that step
2. B. Cancel warfarin independently because every new anticoagulant automatically replaces prior therapy
3. C. Hold automatic dispensing and have the pharmacist evaluate the transition or combination before both anticoagulants overlap
4. D. Reclassify apixaban as an antiplatelet so the duplication alert no longer appears

Answer choices

1. A. Every package sharing the expiration date, regardless of product or lot
2. B. Only inventory matching the recalled product and lot identified in the notice
3. C. Only inventory with a different lot because unaffected batches require investigation
4. D. No inventory because an expiration date always replaces lot information

Answer choices

1. A. Keep the routine process because Form 222 and CSOS apply only to Schedule V
2. B. Use paper Form 222 because CSOS can never be used electronically
3. C. Share the CSOS certificate because secure credentials work only when everyone can access them
4. D. Order Schedule II stock with DEA Form 222 or CSOS and protect the CSOS certificate from unauthorized use

Answer choices

1. A. Accept the signature because two employees participated in the workflow
2. B. Ask the first technician to repeat the result until the coworker agrees
3. C. Repeat the check independently from the source data before the dose advances
4. D. Skip the calculation because standardized workflows are optional after an interruption

Answer choices

1. A. Treat fluticasone as scheduled maintenance, not acute rescue; refer role confusion
2. B. Confirm attack-only use because absence of symptoms makes maintenance therapy unnecessary
3. C. Relabel fluticasone as immediate relief because all inhaled products have the same indication
4. D. Remove the maintenance directions and retain only as-needed attack use